Answers are grounded in this paper and cite their sources.
Shows blood biomarkers are insufficient for accurate differential diagnosis in hyperacute stroke, indicating need for novel markers and improved laboratory methods.
The studied biomarkers were not sufficient for an accurate differential diagnosis of stroke in the hyperacute setting. Additional discovery of new biomarkers and improvement on laboratory techniques seem necessary for achieving a molecular diagnosis of stroke.
No takes yet. Share an insight, caveat, or question.
Bustamante et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: